Advertisement
Organisation › Details
Novozymes (Group)
Novozymes is the world leader in biological solutions. Together with customers, partners, and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. *
Predecessor | Novo Nordisk (Group) | |
Industry | industrial enzyme | |
Industry 2 | industrial biotechnology | |
City | n. a. | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | F: 1,001 to 5,000 (2006-07-13) |
Currency | DKK | |
Annual sales | 6,281,000,000 (sales (2005) 2005-12-31) | |
Profit | 861,000,000 (2005-12-31) | |
* Document for »About Section«: Novozymes A/S. (12/12/22). "Press Release: Novozymes and Chr. Hansen to Combine and Create a Leading Global Biosolutions Partner [Not for US, CA, et al.]". Copenhagen. | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Novozymes (Group)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top